Skip to Content

Invanz (ertapenem sodium) Injection

Audience: Infectious disease specialists, hospital administrators and pharmacists, other healthcare professionals

[Posted 07/05/2007] Merck and FDA informed healthcare professionals that 3 lots of Invanz (0803930, 0803940, and 0803950), a product indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated microorganisms, were recalled. The product was recalled because of two incidents of finding broken glass pieces in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. No other lots are affected by this recall.

[July 02, 2007 - Dear Healthcare Professional Letter - Merck]

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.